Tags

Type your tag names separated by a space and hit enter

[Malaria chemoprophylaxis in 2005: new policy, new drugs].
Rev Prat. 2005 Apr 30; 55(8):849-61.RP

Abstract

For a traveller visiting highly endemic areas for malaria (mainly sub-Saharan Africa), the use of a chemoprophylaxis has to be considered as mandatory in addition to exposure prophylaxis measures (including in migrants largely over-represented among returning travellers with imported malaria). The choice of the appropriate drug depends mainly on the visited area with regard to the level of resistance to chloroquine. Due to the spread of resistance, 7 countries along the West African coast between Senegal and Côte d'Ivoire moved in 2005 from zone 2 to zone 3 (according to the French classification). Recently available and recommanded in zones 2 and 3, the atovaquone+proguanil combination appears to be of great interest due to a good tolerance and an intake limited to the 7 days following return. Alternatively to mefloquine or atovaquone+proguanil, the well tolerated and cheap doxycycline is a good choice but due to its short half life a full compliance is mandatory. In case of fever, even if a chemoprophylaxis is taken, malaria can develop, sometimes with atypical presentations, and has to be systematically considered.

Authors+Show Affiliations

Service de parasitologie-mycologie, département des maladies infectieuses, parasitaires et tropicales, groupe hospitalier La Pitié-La Salpêtrière, 75651 Paris Cedex 13. martin.danis@psl.ap-hop-paris.frNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

fre

PubMed ID

15999839

Citation

Danis, Martin, et al. "[Malaria Chemoprophylaxis in 2005: New Policy, New Drugs]." La Revue Du Praticien, vol. 55, no. 8, 2005, pp. 849-61.
Danis M, Legros F, Brousse G, et al. [Malaria chemoprophylaxis in 2005: new policy, new drugs]. Rev Prat. 2005;55(8):849-61.
Danis, M., Legros, F., & Brousse, G. (2005). [Malaria chemoprophylaxis in 2005: new policy, new drugs]. La Revue Du Praticien, 55(8), 849-61.
Danis M, et al. [Malaria Chemoprophylaxis in 2005: New Policy, New Drugs]. Rev Prat. 2005 Apr 30;55(8):849-61. PubMed PMID: 15999839.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Malaria chemoprophylaxis in 2005: new policy, new drugs]. AU - Danis,Martin, AU - Legros,Fabrice, AU - Brousse,Geneviève, AU - ,, PY - 2005/7/8/pubmed PY - 2005/8/12/medline PY - 2005/7/8/entrez SP - 849 EP - 61 JF - La Revue du praticien JO - Rev Prat VL - 55 IS - 8 N2 - For a traveller visiting highly endemic areas for malaria (mainly sub-Saharan Africa), the use of a chemoprophylaxis has to be considered as mandatory in addition to exposure prophylaxis measures (including in migrants largely over-represented among returning travellers with imported malaria). The choice of the appropriate drug depends mainly on the visited area with regard to the level of resistance to chloroquine. Due to the spread of resistance, 7 countries along the West African coast between Senegal and Côte d'Ivoire moved in 2005 from zone 2 to zone 3 (according to the French classification). Recently available and recommanded in zones 2 and 3, the atovaquone+proguanil combination appears to be of great interest due to a good tolerance and an intake limited to the 7 days following return. Alternatively to mefloquine or atovaquone+proguanil, the well tolerated and cheap doxycycline is a good choice but due to its short half life a full compliance is mandatory. In case of fever, even if a chemoprophylaxis is taken, malaria can develop, sometimes with atypical presentations, and has to be systematically considered. SN - 0035-2640 UR - https://www.unboundmedicine.com/medline/citation/15999839/[Malaria_chemoprophylaxis_in_2005:_new_policy_new_drugs]_ L2 - https://www.diseaseinfosearch.org/result/4415 DB - PRIME DP - Unbound Medicine ER -